Jump to content

Monstera epipremnoides

From Wikipedia, the free encyclopedia

Monstera epipremnoides
Monstera epipremnoides
Scientific classification Edit this classification
Kingdom: Plantae
Clade: Tracheophytes
Clade: Angiosperms
Clade: Monocots
Order: Alismatales
Family: Araceae
Genus: Monstera
Species:
M. epipremnoides
Binomial name
Monstera epipremnoides

Monstera epipremnoides is a species of flowering plant in the family Araceae, endemic to Costa Rica and Panama.[1][2][3]]].[4] When mature, its leaf blades are up to approximately 70cm in length and they are pinnatifid, with perforations regularly splitting through the leaf margin, dividing the leaves so that they have three to 15 lobes per side of the leaf, often with long internal fenestrations running along them.[5]

Confusion

[edit]

A clone of another plant in cultivation was formerly thought to be of this species, but, in 2018, after comparison with wild populations of M. epipremnoides, the plant in cultivation was determined to be an undescribed species closer to Monstera lechleriana and, although it is believed to be a species collected from an unknown location in the wild, was registered under the cultivar name 'Esqueleto'.[6]

References

[edit]
  1. ^ Kew World Checklist of Selected Plant Families
  2. ^ Govaerts, R. & Frodin, D.G. (2002). World Checklist and Bibliography of Araceae (and Acoraceae): 1-560. The Board of Trustees of the Royal Botanic Gardens, Kew.
  3. ^ Hammel, B.E. & al. (2003). Manual de Plantas de Costa Rica 2: 1-694. Missouri Botanical Garden Press, St. Louis.
  4. ^ Cedeño Fonseca, Marco Vinicio; Hay, Alistair; Blanco Coto, Mario Alberto (2022). "A taxonomic revision of Monstera Adans. (Araceae: Monsteroideae) in Costa Rica". Aroideana. 45 (1): 4–. Retrieved 7 June 2025.
  5. ^ Cedeño Fonseca, Marco Vinicio; Hay, Alistair; Blanco Coto, Mario Alberto (2022). "A taxonomic revision of Monstera Adans. (Araceae: Monsteroideae) in Costa Rica". Aroideana. 45 (1): 4–. Retrieved 7 June 2025.
  6. ^ "Monstera, Esqueleto". Mysite. Retrieved 2021-09-30.